Bladder Cancer,Genitourinary Cancer Neoadjuvant Atezolizumab in MIBC Patients Ineligible for Cisplatin: ABACUS in Phase 2 Trial Apr 20, 2023
Bladder Cancer,Genitourinary Cancer Phase 2 BAYOU Trial: Investigating the Efficacy of Durvalumab and Olaparib in Platinum-Ineligible Bladder Cancer Apr 20, 2023
Bladder Cancer,Genitourinary Cancer Phase 2 RACE IT Study: Revolutionizing Treatment for Urothelial Carcinoma Patients Apr 20, 2023
Bladder Cancer,Genitourinary Cancer Neoadjuvant Pembrolizumab in MIBC: PURE-01 Follow Up Trial Apr 20, 2023
Bladder Cancer,Genitourinary Cancer Enfortumab Vedotin vs. Standard Chemotherapy for Advanced Urothelial Cancer: Phase 3 Results from EV-301 Apr 20, 2023
Bladder Cancer,Genitourinary Cancer CheckMate 274 Trial: Adjuvant Nivolumab vs Placebo in MIUC Analysis Mar 14, 2023
Bladder Cancer,Genitourinary Cancer JAVELIN Bladder 100: Avelumab for Advanced UC in Subgroups Mar 14, 2023
Bladder Cancer,Genitourinary Cancer,Popular PURE-01 Trial: Neoadjuvant Pembrolizumab and Radical Cystectomy in MIBC Patients Feb 24, 2023
